Adaptive Biotechnologies Files 8-K
Ticker: ADPT · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1478320
| Field | Detail |
|---|---|
| Company | Adaptive Biotechnologies Corp (ADPT) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $15 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, other-events
Related Tickers: ADPT
TL;DR
ADPT filed an 8-K on 12/30/25 for 'Other Events' - keep an eye out.
AI Summary
Adaptive Biotechnologies Corporation filed an 8-K on December 30, 2025, reporting other events. The company, incorporated in Washington with its principal executive offices in Seattle, operates in the biological products sector.
Why It Matters
This filing indicates a report of 'Other Events' by Adaptive Biotechnologies, which could signify significant but not immediately classifiable corporate developments.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting 'Other Events' without immediate financial or operational disclosures, suggesting a low immediate risk.
Key Numbers
- 001-38957 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-0907024 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Adaptive Biotechnologies Corporation (company) — Registrant
- Washington (location) — State of Incorporation
- Seattle (location) — Principal Executive Offices City
- December 30, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by Adaptive Biotechnologies in this 8-K filing?
The provided text is a header and does not detail the specific 'Other Events' reported; it only indicates that the filing pertains to this item.
When was this 8-K report filed by Adaptive Biotechnologies?
The report was filed as of December 30, 2025.
What is Adaptive Biotechnologies Corporation's principal executive office location?
The principal executive offices are located at 1165 Eastlake Avenue East, Seattle, Washington, 98109.
What is the SIC code for Adaptive Biotechnologies Corporation?
The Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
What was Adaptive Biotechnologies' former company name and when did the name change occur?
The company's former name was Adaptive TCR Corp, and the date of the name change was December 9, 2009.
Filing Stats: 644 words · 3 min read · ~2 pages · Grade level 16.4 · Accepted 2025-12-30 08:00:14
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share ADPT The Nasdaq Stock Mar
- $15 million — roceeds in the financing round of up to $15 million. Upon completion of the Series A round,
Filing Documents
- d81101d8k.htm (8-K) — 24KB
- 0001193125-25-335921.txt ( ) — 131KB
- adpt-20251230.xsd (EX-101.SCH) — 3KB
- adpt-20251230_lab.xml (EX-101.LAB) — 17KB
- adpt-20251230_pre.xml (EX-101.PRE) — 11KB
- d81101d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Adaptive Biotechnologies Corporation Date: December 30, 2025 By: /s/ Kyle Piskel Kyle Piskel Chief Financial Officer